
Reset all filters
01 8Bayer AG
02 4Novo Nordisk
03 6Takeda Pharmaceutical
Reset all filters
01 10KIT
02 8POWDER FOR SOLUTION
Reset all filters
01 18Schedule D
Reset all filters
01 5ADYNOVATE
02 4ESPEROCT
03 3JIVI
04 5KOVALTRY
05 1OBIZUR
Reset all filters
01 18Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 250UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451441
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 500UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451468
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 1000UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451476
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 2000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2451484
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 3000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2451492
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging : 500
Approval Date :
Application Number : 2481766
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2481774
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 3000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2481790
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490064
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490072
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490099
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 3000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490102
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ADYNOVATE
Dosage Form : KIT
Dosage Strength : 250UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2498537
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ADYNOVATE
Dosage Form : KIT
Dosage Strength : 500UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2498545
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ADYNOVATE
Dosage Form : KIT
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2498588
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ADYNOVATE
Dosage Form : KIT
Dosage Strength : 3000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2498626
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ADYNOVATE
Dosage Form : KIT
Dosage Strength : 2000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2459078
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : OBIZUR
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/ML
Packaging : 1ML RECONST. IN 3ML VIAL
Approval Date :
Application Number : 2447401
Regulatory Info : Schedule D
Registration Country : Canada